Pregled Radovi istraživača / Researchers' publications autora: "Haribabu, Jebiti"
Prikaz rezultata 1-5 od 5
-
An ESIPT active coumarin-diphenyl azine-based AIEgen: Nanomolar Cu2+ ion sensing, Latent Fingerprinting, live-cell imaging, and real sample analysis
Jain, Abhinav; De, Soumik; Saraswat, Pranjal; Haribabu, Jebiti; Santibanez, Juan F.; Barman, Pranjit (Elsevier, 2024) -
Effect of coordination mode of thiosemicarbazone on the biological activities of its Ru(II)-benzene complexes: Biomolecular interactions and anticancer activity via ROS-mediated mitochondrial apoptosis
Haribabu, Jebiti; Arulkumar, Rasu; Mahendiran, Dharmasivam; Jeyalakshmi, Kumaramangalam; Swaminathan, Srividya; Venuvanalingam, Ponnambalam; Bhuvanesh, Nattamai; Santibanez, Juan F.; Karvembu, Ramasamy (Elsevier, 2024) -
Exploring the anticancer potential of thiadiazole derivatives of substituted thiosemicarbazones formed via copper-mediated cyclization
Vadakkedathu Palakkeezhillam, Vishnunarayanan Namboothiri; Haribabu, Jebiti; Suresh Kumar, Vaishnu; Manakkadan, Vipin; Rasin, Puthiyavalappil; Bhuvanesh, Nattamai; Echeverria, Cesar; Santibanez, Juan F.; Sreekanth, Anandaram (Wiley-Blackwell, 2023) -
Host-guest interactions of coumarin-based 1,2-pyrazole using analytical and computational methods: Paper strip-based detection, live cell imaging, logic gates and keypad lock applications
Rasin, Puthiyavalappil; Basheer, Sabeel M.; Haribabu, Jebiti; Aneesrahman, K. N.; Manakkadan, Vipin; Vadakkedathu Palakkeezhillam, Vishnunarayanan Namboothiri; Bhuvanesh, Nattamai; Echeverria, Cesar; Santibanez, Juan F.; Sreekanth, Anandaram (Elsevier, 2024) -
Unraveling the Anticancer Efficacy and Biomolecular Properties of Ru(II)-Arene Complexes of Pyrene-Based Thiosemicarbazone Ligands: A Comprehensive In Silico/In Vitro Exploration
Vadakkedathu Palakkeezhillam, Vishnunarayanan Namboothiri; Haribabu, Jebiti; Suresh Kumar, Vaishnu; Santibanez, Juan F.; Manakkadan, Vipin; Rasin, Puthiyavalappil; Garg, Mohit; Bhuvanesh, Nattamai; Sreekanth, Anandaram (American Chemical Society, 2024)